The Murcia Cancer Registry was created in 1981. It has incidence data since 1982.

The registry work team is made up of: Dra. Maria Dolores Chirlaque (Director), Dr. Antonia Sánchez Gil (coordinator), Dr. Ricardo José Vaamonde (pathologist and preventivist), Jacinta Tortosa (nurse), Mercedes Expósito (nurse) , Sandra Mª Garrido (nurse), María José Sánchez (coder), and Mónica Ballesta (statistics).

• Register of malignant tumors diagnosed in people residing in the Murcia Region, collection of cases, coding, control and quality indicators, production of incidence statistics and reporting.
• It is part of the European Prospective Study on Diet, Cancer and Health (EPIC) and the Multicase-Control Study in Spain (MCC-SPAIN).
• Follow-up of vital status of registered patients, participating in the study on cancer survival in Europe (EUROCARE) and in the world (CONCORD).
• Collaboration in the European RARECARE project on rare malignant tumors.
• Contribution to the estimation of the prevalence of cancer in Europe.
• Participates in different multicenter projects on childhood tumors, adolescent tumors, breast cancer, gynecological, hematological, colorectal and prostate cancer.

IARC, ENCR, CIFC, ACCIS, EUROCIM, EUROCARE, RARECARE, EPIC, MCC-SPAIN, REDEPICAN, CONCORD

• Locati L, Cavalieri S, Dal Maso L, Busco S, Anderson L, Botta L, Bento MJ, Carulla M, Chirlaque López MD, Fusco M, Guevara M, Innos K, BørgeJohannesen T, Micallef R, Minicozzi P, Panato C, Petrova D, Rubio Casadevall J, Smailyte G, Vitale MF, Trama A. Rare thyroid malignancies in Europe: Data from the informationnetwork on rare cancers in Europe (RARECAREnet). Oral Oncol . 2020 Sep;108:104766. Epub 2020 May 23.
• Sacchetto L, Zanetti R, Comber H, Bouchardy C, Brewster DH, Broganelli P, Chirlaque MD, Coza D, Galceran J, Gavin A, Hackl M, Katalinic A, Larønningen S, Louwman MWJ, Morgan E, Robsahm TE, Sanchez MJ, Tryggvadóttir L, Tumino R, Van Eycken E, Vernon S, Zadnik V, Rosso S. Trends in incidence of thick, thin and in situ melanoma in Europe. Eur J Cancer. 2018 Mar;92:108-118. Epub 2018 Jan 31.
• Marcos-Gragera R, Solans M, Galceran J, Fernández-Delgado R, Fernández-Teijeiro A, Mateos A, Quirós-Garcia JR, Fuster-Camarena N, De Castro V, Sánchez MJ, Franch P, Chirlaque MD, Ardanaz E, Martos C, Salmerón D, Peris-Bonet R; Spanish Childhood Cancer Epidemiology Working Group. Childhood and adolescent lymphoma in Spain: incidence and survival trends over 20 years. Clin Transl Oncol. 2018 Oct;20(10):1289-1301. Epub 2018 Apr 5.
• Chirlaque MD, Salmerón D, Galceran J, Ameijide A, Mateos A, Torrella A, Jiménez R, Larrañaga N, Marcos-Gragera R, Ardanaz E, Sant M, Minicozzi P, Navarro C, Sánchez MJ; REDECAN Working Group. Cancer survival in adult patients in Spain. Results from nine population-based cancer registries. Clin Transl Oncol. 2018 Feb;20(2):201-211. Epub 2017 Jul 17.
• Galceran J, Ameijide A, Carulla M, Mateos A, Quirós JR, Rojas D, Alemán A, Torrella A, Chico M, Vicente M, Díaz JM, Larrañaga N, Marcos-Gragera R, Sánchez MJ, Perucha J, Franch P, Navarro C, Ardanaz E, Bigorra J, Rodrigo P, Bonet RP; REDECAN Working Group.  Cancer incidence in Spain, 2015. Clin Transl Oncol. 2017 Jul; 19(7):799-825.
• Larrañaga N, Sánchez MJ, Ardanaz E, Felipe S, Marcos-Gragera R, Ramos M, Carulla M, Chirlaque MD, Argüelles M, Martos C, Mateo A, Peris-Bonet R. Incidence patterns and trends of non-central nervous system solid tumours in children and adolescents. A collaborative study of the Spanish population based cancer registries. J Cancer. 2016; 7(3): 335–343.
• Marcos-Gragera R, Galceran J, Martos C, de Muniain AL, Vicente-Raneda M, Navarro C, Quirós-García JR, Sánchez MJ, Ardanaz E, Ramos M, Mateos M, Salmerón C, Felipe S, Peris-Bonet R. Incidence and survival time trends for Spanish children and adolescents with leukaemia from 1983 to 2007. Clin Transl Oncol. 2017 Mar;19(3):301-316. Epub 2016 Jul 22.
• Chirlaque MD, Salmerón D, Galceran J, Ameijide A, Mateos A, Torrella A, Jiménez R, Larrañaga N, Marcos-Gragera R, Ardanaz E, Sant M, Minicozzi P, Navarro C, Sánchez MJ; REDECAN Working Group. Cancer survival in adult patients in Spain. Results from nine population-based cancer registries. Clin Transl Oncol. 2017 Jul 17.
• Chirlaque MD, Uhry Z, Salmerón D, Sánchez-Zapata MI, Zannoni GF, Navarro C; GRELL EUROCARE-5 Working Group. Trends in net survival from ovarian cancer in six European Latin countries: results from the SUDCAN population-based study. Eur J Cancer Prev. 2017 Jan;26 S107-S113.
• Galceran J, Ameijide A, Carulla M, Mateos A, Quirós JR, Rojas D, Alemán A, Torrella A, Chico M, Vicente M, Díaz JM, Larrañaga N, Marcos-Gragera R, Sánchez MJ, Perucha J, Franch P, Navarro C, Ardanaz E, Bigorra J, Rodrigo P, Bonet RP; REDECAN Working Group.  Cancer incidence in Spain, 2015. Clin Transl Oncol. 2017 Jul; 19(7):799-825.
• Larrañaga N, Sánchez MJ, Ardanaz E, Felipe S, Marcos-Gragera R, Ramos M, Carulla M, Chirlaque MD, Argüelles M, Martos C, Mateo A, Peris-Bonet R. Incidence patterns and trends of non-central nervous system solid tumours in children and adolescents. A collaborative study of the Spanish population based cancer registries. J Cancer. 2016; 7(3): 335–343.
• Stiller CA, Trama A, Serraino D, Rossi S, Navarro C, Chirlaque MD, Casali PG. Descriptive epidemiology of sarcomas in Europe: Report from the RARECARE project. Eur J Cancer. 2013;49(3):684-95.
• Salmerón D, Chirlaque MD, Isabel IM, Sánchez MJ, Marcos-Gragera R, Ardanaz E, Galcerán J, Mateos A, Navarro C. Lung cancer prognosis in Spain: the role of histology, age and sex. Respir Med. 2012;106(9):1301-8.
• Marcos-Gragera R, Salmeron D, Izarzugaza I, Ardanaz E, Serda BC, Larrañaga N, San RE, Navarro C, Chirlaque MD. Trends in prostate cancer survival in Spain: results from population-based cancer registries. Clin Transl Oncol. 2012;14(6):458-64
• Mallone S, De VE, Guzzo M, Midena E, Verne J, Coebergh JW, Marcos-Gragera R, Ardanaz E, Martinez R, Chirlaque MD, Navarro C, Virgili G. Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe. Eur J Cancer. 2012;48(8):1167-75.
• Siesling S, van der Zwan JM, Izarzugaza I, Jaal J, Treasure T, Foschi R, Ricardi U, Groen H, Tavilla A, Ardanaz E [Navarro C, Chirlaque MD]. Rare thoracic cancers, including peritoneum mesothelioma. Eur J Cancer. 2012;48(7):949-60.
• Oberaigner W, Minicozzi P, Bielska-Lasota M, Allemani C, de AR, Mangone L, Sant M [Navarro C, Chirlaque MD]. Survival for ovarian cancer in Europe: the across-country variation did not shrink in the past decade. Acta Oncol. 2012;51(4):441-53.
• Trama A, Mallone S, Nicolai N, Necchi A, Schaapveld M, Gietema J, Znaor A, Ardanaz E, Berrino F [Navarro C, Chirlaque MD]. Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe. Eur J Cancer. 2012;48(2):159-69.
• Van der Zwan JM, Mallone S, van DB, Bielska-Lasota M, Otter R, Foschi R, Baudin E, Links TP [Navarro C, Chirlaque MD]. Carcinoma of endocrine organs: results of the RARECARE project. Eur J Cancer. 2012;48(13):1923-31.
• Sant M, Minicozzi P, Lagorio S, Borge JT, Marcos-Gragera R, Francisci S [Navarro C, Chirlaque MD]. Survival of European patients with central nervous system tumors. Int J Cancer. 2012;131(1):173-85.
• Gavin AT, Francisci S, Foschi R, Donnelly DW, Lemmens V, Brenner H, Anderson LA  [Navarro C, Chirlaque MD]. Oesophageal cancer survival in Europe: a EUROCARE-4 study. Cancer Epidemiol. 2012;36(6):505-12.
• Izarzugaza MI, Ardanaz E, Chirlaque MD, Font C, Ameijide A, Linares C; Lung Cancer Working Group. Tobacco-related tumours of the lung, bladder and larynx: changes in Spain. Ann Oncol 2010; 21 Suppl 3:iii52-60.
• Navarro C, Martos C, Ardanaz E, Galceran J, Izarzugaza I, Peris-Bonet R, Martínez C; Spanish Cancer Registries Working Group. Population-based cancer registries in Spain and their role in cancer control. Ann Oncol 2010; 21 Suppl 3:iii3-13.
• Larrañaga N., Galceran J., Ardanaz E., Franch P., Navarro C., Sánchez MJ., Pastor-Barriuso R., for the Prostate Cancer Working Group (2010). Prostate Cancer Incidence Trends in Spain around the PSA era: impact on mortality. Ann Oncol 2010; 21 Suppl 3:iii83-89.
• Chirlaque MD, Salmerón D, Tortosa J, Valera I, Párraga ME, Ballesta M, Navarro C. Cáncer infantil en la Región de Murcia. Estudio del periodo 1983-2007. Murcia: Consejería de Sanidad y Política Social. D.G. de Salud Pública, 2012. Disponible en http://www.murciasalud.es/publicaciones  
• Chirlaque MD, Tortosa J, Valera I, Párraga E, Salmerón D, Navarro C. Incidencia de cáncer en la Región de Murcia. Periodo 2003-2007.
  Disponible en http://www.murciasalud.es/recursos/ficheros/255323-diciembre2012.pdf 

• Tendencia en la incidencia de cáncer en la Región de Murcia en el periodo 1983-2007. Disponible en 
  http://www.murciasalud.es/recursos/ficheros/243466-Boletin_INDICADORES_SALUD_2011.pdf

• Linfoma no Hodgkin en la Región de Murcia 1994-2003: Análisis espacial. Disponible en
  http://www.murciasalud.es/recursos/ficheros/234064-Boletin_Febrero_LINFOMA.pdf  
• Cáncer de mama. Situación en la región de Murcia. Mayo 2012. Disponible en
  http://www.murciasalud.es/recursos/ficheros/241629-cancer_mama.pdf
• Chirlaque MD, Expósito M, Valera I, Tortosa J, Garrido S, Sánchez MJ, Salmerón D, Navarro C. Incidencia de cáncer en la Región de Murcia. Año 2010. Bol Epidemiol Murcia. 2017;37(809):11-20.

Ver también: http://www.murciasalud.es/epidemiologia

• International benchmarking of population-based childhood cancer survival by stage at diagnosis.
• Comparative analysis of the distribution and time trends of colorectal cancer incidence, mode of detection, stage at diagnosis, and survival rates: an international population-based study.
• VENUS CANCER.